Loading...

Virtus Health

ASX:VRT
Snowflake Description

Good value average dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
VRT
ASX
A$328M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. The last earnings update was 29 days ago. More info.


Add to Portfolio Compare Print
VRT Share Price and Events
7 Day Returns
2%
ASX:VRT
1.6%
AU Healthcare
0.3%
AU Market
1 Year Returns
-28.9%
ASX:VRT
-1%
AU Healthcare
2.2%
AU Market
VRT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Virtus Health (VRT) 2% -2.9% -8.8% -28.9% -34.3% -46.6%
AU Healthcare 1.6% 4.2% 14.1% -1% 0.8% 22.4%
AU Market 0.3% 1.7% 10.1% 2.2% 18.5% 5.5%
1 Year Return vs Industry and Market
  • VRT underperformed the Healthcare industry which returned -1% over the past year.
  • VRT underperformed the Market in Australia which returned 2.2% over the past year.
Price Volatility
VRT
Industry
5yr Volatility vs Market

Value

 Is Virtus Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Virtus Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data    Our intrinsic value calculation method has changed recently, learn more here.

Below are the data sources, inputs and calculation used to determine the intrinsic value for Virtus Health.

ASX:VRT Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.4%
Perpetual Growth Rate 10-Year AU Government Bond Rate 2.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ASX:VRT
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AU Govt Bond Rate 2.3%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.73
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.735 (1 + (1- 30%) (56.19%))
1.016
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.02
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.31% + (1.016 * 5.96%)
8.37%

Discounted Cash Flow Calculation for ASX:VRT using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Virtus Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

ASX:VRT DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 8.37%)
2019 25.20 Analyst x2 23.25
2020 38.77 Analyst x3 33.01
2021 38.75 Analyst x2 30.45
2022 36.17 Analyst x1 26.23
2023 34.68 Est @ -4.13% 23.21
2024 33.92 Est @ -2.2% 20.94
2025 33.63 Est @ -0.84% 19.16
2026 33.67 Est @ 0.1% 17.70
2027 33.92 Est @ 0.77% 16.46
2028 34.34 Est @ 1.23% 15.38
Present value of next 10 years cash flows A$225.81
ASX:VRT DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$34.34 × (1 + 2.31%) ÷ (8.37% – 2.31%)
A$580.38
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$580.38 ÷ (1 + 8.37%)10
A$259.89
ASX:VRT Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$225.81 + A$259.89
A$485.69
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$485.69 / 80.39
A$6.04
ASX:VRT Discount to Share Price
Calculation Result
Value per share (AUD) From above. A$6.04
Current discount Discount to share price of A$4.06
= -1 x (A$4.06 - A$6.04) / A$6.04
32.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Virtus Health is available for.
Intrinsic value
33%
Share price is A$4.06 vs Future cash flow value of A$6.04
Current Discount Checks
For Virtus Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Virtus Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Virtus Health's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Virtus Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Virtus Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:VRT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$0.36
ASX:VRT Share Price ** ASX (2019-03-19) in AUD A$4.06
Australia Healthcare Industry PE Ratio Median Figure of 23 Publicly-Listed Healthcare Companies 18.59x
Australia Market PE Ratio Median Figure of 543 Publicly-Listed Companies 16.33x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Virtus Health.

ASX:VRT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:VRT Share Price ÷ EPS (both in AUD)

= 4.06 ÷ 0.36

11.33x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Virtus Health is good value based on earnings compared to the AU Healthcare industry average.
  • Virtus Health is good value based on earnings compared to the Australia market.
Price based on expected Growth
Does Virtus Health's expected growth come at a high price?
Raw Data
ASX:VRT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 11.33x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
3.5%per year
Australia Healthcare Industry PEG Ratio Median Figure of 17 Publicly-Listed Healthcare Companies 1.81x
Australia Market PEG Ratio Median Figure of 362 Publicly-Listed Companies 1.37x

*Line of best fit is calculated by linear regression .

ASX:VRT PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 11.33x ÷ 3.5%

3.24x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Virtus Health is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Virtus Health's assets?
Raw Data
ASX:VRT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$3.50
ASX:VRT Share Price * ASX (2019-03-19) in AUD A$4.06
Australia Healthcare Industry PB Ratio Median Figure of 28 Publicly-Listed Healthcare Companies 1.47x
Australia Market PB Ratio Median Figure of 1,670 Publicly-Listed Companies 1.67x
ASX:VRT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:VRT Share Price ÷ Book Value per Share (both in AUD)

= 4.06 ÷ 3.50

1.16x

* Primary Listing of Virtus Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Virtus Health is good value based on assets compared to the AU Healthcare industry average.
X
Value checks
We assess Virtus Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Virtus Health has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Virtus Health expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
3.5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Virtus Health expected to grow at an attractive rate?
  • Virtus Health's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
  • Virtus Health's earnings growth is positive but not above the Australia market average.
  • Virtus Health's revenue growth is expected to exceed the Australia market average.
Annual Growth Rates Comparison
Raw Data
ASX:VRT Future Growth Rates Data Sources
Data Point Source Value (per year)
ASX:VRT Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 3.5%
ASX:VRT Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 3.5%
Australia Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9%
Australia Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.4%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:VRT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:VRT Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-06-30 308 28 1
2021-06-30 300 49 32 4
2020-06-30 289 48 32 5
2019-06-30 280 39 28 4
ASX:VRT Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 269 39 29
2018-09-30 265 47 30
2018-06-30 262 55 31
2018-03-31 260 54 30
2017-12-31 259 53 30
2017-09-30 258 46 29
2017-06-30 257 39 28
2017-03-31 258 41 29
2016-12-31 260 43 30
2016-09-30 261 46 31
2016-06-30 261 48 33
2016-03-31 257 44 32

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Virtus Health's earnings are expected to grow by 3.5% yearly, however this is not considered high growth (20% yearly).
  • Virtus Health's revenue is expected to grow by 3.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:VRT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Virtus Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:VRT Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-06-30 0.33 0.33 0.33 1.00
2021-06-30 0.36 0.40 0.30 3.00
2020-06-30 0.38 0.48 0.30 5.00
2019-06-30 0.34 0.37 0.30 4.00
ASX:VRT Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 0.36
2018-09-30 0.37
2018-06-30 0.38
2018-03-31 0.38
2017-12-31 0.37
2017-09-30 0.36
2017-06-30 0.35
2017-03-31 0.36
2016-12-31 0.37
2016-09-30 0.39
2016-06-30 0.41
2016-03-31 0.40

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Virtus Health is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Virtus Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Virtus Health has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Virtus Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Virtus Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Virtus Health's year on year earnings growth rate has been positive over the past 5 years.
  • Virtus Health's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Virtus Health's 1-year earnings growth is negative, it can't be compared to the AU Healthcare industry average.
Earnings and Revenue History
Virtus Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Virtus Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:VRT Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 268.94 28.81 26.89
2018-09-30 265.50 29.78 25.78
2018-06-30 262.06 30.75 24.68
2018-03-31 260.48 30.36 23.95
2017-12-31 258.89 29.96 23.21
2017-09-30 257.71 29.03 23.15
2017-06-30 256.52 28.10 23.09
2017-03-31 258.41 28.94 23.33
2016-12-31 260.30 29.78 23.58
2016-09-30 260.76 31.35 23.10
2016-06-30 261.21 32.92 22.63
2016-03-31 256.61 31.76 21.74
2015-12-31 252.00 30.60 20.85
2015-09-30 243.07 30.02 20.62
2015-06-30 234.14 29.43 20.39
2015-03-31 224.32 30.04 19.28
2014-12-31 214.50 30.64 18.17
2014-09-30 208.02 30.76 16.94
2014-06-30 201.55 30.89 15.72
2014-03-31 197.94 23.43 15.79
2013-12-31 194.33 15.97 15.86
2013-09-30 190.62 13.04 15.63
2013-06-30 186.90 10.10 15.39
2013-03-31 182.68 15.22 15.10
2012-12-31 178.46 20.33 14.80
2012-09-30 171.98 20.00 14.67
2012-06-30 165.49 19.66 14.53

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Virtus Health has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Virtus Health used its assets more efficiently than the AU Healthcare industry average last year based on Return on Assets.
  • Virtus Health's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Virtus Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Virtus Health has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Virtus Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Virtus Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Virtus Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Virtus Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Virtus Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Virtus Health Company Filings, last reported 2 months ago.

ASX:VRT Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 291.82 184.30 18.82
2018-09-30 291.82 184.30 18.82
2018-06-30 283.55 184.48 21.71
2018-03-31 283.55 184.48 21.71
2017-12-31 277.95 148.42 28.69
2017-09-30 277.95 148.42 28.69
2017-06-30 268.37 154.53 27.34
2017-03-31 268.37 154.53 27.34
2016-12-31 263.88 159.47 23.97
2016-09-30 263.88 159.47 23.97
2016-06-30 258.04 149.14 22.22
2016-03-31 258.04 149.14 22.22
2015-12-31 254.69 153.42 19.08
2015-09-30 254.69 153.42 19.08
2015-06-30 246.32 152.97 18.37
2015-03-31 246.32 152.97 18.37
2014-12-31 245.65 147.89 9.66
2014-09-30 245.65 147.89 9.66
2014-06-30 239.63 139.62 21.50
2014-03-31 239.63 139.62 21.50
2013-12-31 236.05 131.29 19.39
2013-09-30 236.05 131.29 19.39
2013-06-30 214.59 144.20 12.49
2013-03-31 214.59 144.20 12.49
2012-12-31 142.64 218.17 20.62
2012-09-30 142.64 218.17 20.62
2012-06-30 224.99 106.72 9.44
  • Virtus Health's level of debt (63.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (55.6% vs 63.2% today).
  • Debt is well covered by operating cash flow (21.4%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 5.3x coverage).
X
Financial health checks
We assess Virtus Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Virtus Health has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Virtus Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
5.91%
Current annual income from Virtus Health dividends. Estimated to be 6.04% next year.
If you bought A$2,000 of Virtus Health shares you are expected to receive A$118 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Virtus Health's pays a higher dividend yield than the bottom 25% of dividend payers in Australia (2.59%).
  • Virtus Health's dividend is above the markets top 25% of dividend payers in Australia (5.72%).
Upcoming dividend payment

Purchase Virtus Health on or before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:VRT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Australia Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 3.1%
Australia Market Average Dividend Yield Market Cap Weighted Average of 418 Stocks 4.4%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.6%
Australia Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:VRT Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2022-06-30 0.23 1.00
2021-06-30 0.25 4.00
2020-06-30 0.26 5.00
2019-06-30 0.23 4.00
ASX:VRT Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-02-18 0.240 5.906
2018-08-20 0.260 5.341
2018-02-19 0.260 4.611
2017-08-21 0.250 4.676
2017-02-20 0.280 4.986
2016-08-22 0.300 4.582
2016-02-22 0.280 4.141
2015-08-24 0.270 4.616
2014-08-25 0.280 4.023
2014-02-25 0.240 3.039
2013-06-11 0.820 10.416

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Virtus Health has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Virtus Health has only been paying a dividend for 6 years, and since then dividends per share have fallen.
Current Payout to shareholders
What portion of Virtus Health's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.5x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.6x coverage).
X
Income/ dividend checks
We assess Virtus Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Virtus Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Virtus Health has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Virtus Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Sue Channon
COMPENSATION A$721,941
AGE 61
TENURE AS CEO 8.3 years
CEO Bio

Ms. Susan Channon, also known as Sue, has been the Chief Executive Officer at Virtus Health Limited since November 2010 and serves as its Managing Director. Ms. Channon served as the Chief Executive Officer of IVF Australia Pty Ltd. Ms. Channon was State Manager for NSW and ACT for Medical Imaging Australia and the National Director of Nursing for Mayne Group (now part of Ramsay Health Care). Ms. Channon served as Chief Executive Officer of Kareena Private Hospital, Castlecrag, Mosman Private Hospital and Castlecrag Private Hospital. Ms. Channon served as Director of Nursing at Castlecrag Private Hospital. She has held senior management positions in various Australian healthcare organisations for over 20 years. Ms. Channon serves as an Executive Director of Virtus Health Limited. She is Registered Nurse Div1 and holds OR Management Certificate.

CEO Compensation
  • Sue's compensation has increased by more than 20% in the past year.
  • Sue's remuneration is about average for companies of similar size in Australia.
Management Team Tenure

Average tenure and age of the Virtus Health management team in years:

8.3
Average Tenure
60
Average Age
  • The average tenure for the Virtus Health management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Sue Channon

TITLE
CEO, MD & Director
COMPENSATION
A$722K
AGE
61
TENURE
8.3 yrs

Glenn Powers

TITLE
CFO & Company Secretary
COMPENSATION
A$587K
AGE
58
TENURE
10.6 yrs

Steve Zappia

TITLE
Managing Director of Queensland & Virtus Health Diagnostics
COMPENSATION
A$344K
AGE
59

Nadia Stankovic

TITLE
Managing Director of New South Wales
COMPENSATION
A$284K
TENURE
4.8 yrs

Jade Phelan

TITLE
Managing Director of Victoria
COMPENSATION
A$333K
TENURE
2.3 yrs

Richard Banks

TITLE
Managing Director of Europe
COMPENSATION
A$391K
TENURE
1.6 yrs

Lyndon Hale

TITLE
Medical Director of Victoria & Executive Director
COMPENSATION
A$169K
AGE
61
TENURE
11.2 yrs

Peter Illingworth

TITLE
Medical Director of New South Wales
COMPENSATION
A$211K

David Molloy

TITLE
Meidcal Director of Queensland Fertility Group Pty Limited
COMPENSATION
A$131K
TENURE
15.2 yrs

Bill Watkins

TITLE
Medical Director of Tasmania
COMPENSATION
A$41K
Board of Directors Tenure

Average tenure and age of the Virtus Health board of directors in years:

4.5
Average Tenure
61
Average Age
  • The tenure for the Virtus Health board of directors is about average.
Board of Directors

Peter Macourt

TITLE
Chairman of the Board
COMPENSATION
A$146K
TENURE
5.8 yrs

Sue Channon

TITLE
CEO, MD & Director
COMPENSATION
A$722K
AGE
61

Lyndon Hale

TITLE
Medical Director of Victoria & Executive Director
COMPENSATION
A$169K
AGE
61
TENURE
5.8 yrs

Sonia Petering

TITLE
Non-Executive Director
COMPENSATION
A$95K
AGE
47
TENURE
4.5 yrs

Greg Couttas

TITLE
Non-Executive Director
COMPENSATION
A$95K
TENURE
2.4 yrs

Shane Solomon

TITLE
Non-Executive Director
TENURE
0.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
19. Feb 19 Buy Orbis Investment Management Limited Company 15. Oct 18 15. Feb 19 2,507,031 A$4.72 A$11,599,450
19. Oct 18 Sell Challenger Limited Company 16. Oct 18 16. Oct 18 -1,385,432 A$5.26 A$-7,287,371
19. Oct 18 Buy Challenger Limited Company 23. Jul 18 03. Sep 18 240,735 A$5.91 A$1,388,122
23. Jul 18 Sell NovaPort Capital Pty Limited Company 21. Dec 17 19. Jul 18 -731,276 A$5.73 A$-4,189,938
23. Jul 18 Buy NovaPort Capital Pty Limited Company 14. Sep 17 02. Jul 18 224,155 A$5.36 A$1,201,541
13. May 18 Buy Sonia Petering Individual 11. May 18 11. May 18 2,100 A$5.79 A$12,159
11. May 18 Buy Gregory Couttas Individual 10. May 18 10. May 18 1,252 A$5.80 A$7,262
X
Management checks
We assess Virtus Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Virtus Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Why Virtus Health Limited’s (ASX:VRT) Cash Is A Factor You Need To Consider

I’ve analysed below, the health and outlook of Virtus Health’s cash flow, which will help you understand the stock from a cash standpoint. … Virtus Health’s free cash flow (FCF) is the level of cash flow the business generates from its operational activities, after it reinvests in the company as capital expenditure. … There are two methods I will use to evaluate the quality of Virtus Health’s FCF: firstly, I will measure its FCF yield relative to the market index yield; secondly, I will examine whether its operating cash flow will continue to grow into the future, which will give us a sense of sustainability

Simply Wall St -

Are Virtus Health Limited’s (ASX:VRT) Returns Worth Your While?

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Is Virtus Health Limited (ASX:VRT) A Great Dividend Stock?

Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. … Historically, Virtus Health Limited (ASX:VRT) has paid dividends to shareholders, and these days it yields 6.0%. … Does Virtus Health tick all the boxes of a great dividend stock?

Simply Wall St -

How Do Analysts See Virtus Health Limited (ASX:VRT) Performing In The Year Ahead?

Help shape the future of investing tools and you could win a $250 gift card! … In June 2018, Virtus Health Limited (ASX:VRT) released its earnings update. … the higher past 5-year average growth rate of 9.4%.

Simply Wall St -

What Should You Know About Virtus Health Limited's (ASX:VRT) Earnings Trend?

Want to participate in a short research study? … Help shape the future of investing tools and you could win a $250 gift card! … Virtus Health Limited's (ASX:VRT) most recent earnings announcement in June 2018a

Simply Wall St -

Did Virtus Health Limited's (ASX:VRT) Recent Earnings Growth Beat The Trend?

Below, I will assess VRT's recent performance announced on 30 June 2018 and compare these figures to its historical trend and industry movements. … Did VRT beat its long-term earnings growth trend and its industry. … However, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 9.4%, indicating the rate at which VRT is growing has slowed down.

Simply Wall St -

Does Virtus Health Limited (ASX:VRT) Have A Good P/E Ratio?

We'll look at Virtus Health Limited's (ASX:VRT) P/E ratio and reflect on what it tells us about the company's share price. … Virtus Health has a P/E ratio of 11.27, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

What Investors Should Know About Virtus Health Limited's (ASX:VRT) Financial Strength

While small-cap stocks, such as Virtus Health Limited (ASX:VRT) with its market cap of AU$346m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … Evaluating financial health as part of your investment thesis is

Simply Wall St -

How Much Of Virtus Health Limited (ASX:VRT) Do Institutions Own?

Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Companies that used to be publicly owned tend to have lower insider ownership. … Virtus Health is a smaller company with a market capitalization of AU$347m, so it may still be flying under the radar of many institutional investors.

Simply Wall St -

Have You Considered This Before Investing In Virtus Health Limited (ASX:VRT)?

Two important questions to ask before you buy Virtus Health Limited (ASX:VRT) is, how it makes money and how it spends its cash. … Today we will examine Virtus Health’s ability to generate cash flows, as well as the level of capital expenditure it is expected to incur over the next couple of years, which will result in how much money goes to you. … Free cash flow (FCF) is the amount of cash Virtus Health has left after it pays off its expenses, including its net capital expenditures, which is what the company needs to spend each year to maintain or grow its business operations.

Simply Wall St -

Company Info

Description

Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. It also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, the company offers day hospital procedures, such as IVF, endoscopy, gynaecology, urology, dental, ophthalmic, cosmetic surgery, and plastic surgery. As of August 21, 2018, it operated through a network of 126 fertility specialists. The company was founded in 2008 and is headquartered in Greenwich, Australia.

Details
Name: Virtus Health Limited
VRT
Exchange: ASX
Founded: 2008
A$327,990,947
80,389,938
Website: http://www.virtushealth.com.au
Address: Virtus Health Limited
176 Pacific Highway,
Level 3,
Greenwich,
New South Wales, 2065,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX VRT Ordinary Shares Australian Securities Exchange AU AUD 11. Jun 2013
DB V6H Ordinary Shares Deutsche Boerse AG DE EUR 11. Jun 2013
CHIA VRT Ordinary Shares Chi-X Australia AU AUD 11. Jun 2013
Number of employees
Current staff
Staff numbers
1,300
Virtus Health employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/19 10:34
End of day share price update: 2019/03/19 00:00
Last estimates confirmation: 2019/02/26
Last earnings filing: 2019/02/18
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.